← All trials
NCT04847661
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 28, 2021
- Primary completion
- Jul 30, 2021
- Completion date
- Aug 30, 2021
- First posted
- Apr 19, 2021
- Last posted
- Apr 19, 2021
- Enrollment
- 1500
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Helwan UniversityLead sponsor
- Assiut UniversityCollaborator
- Ain Shams UniversityCollaborator
- Tanta UniversityCollaborator
- Helwan UniversityReponsible party - principal investigator
- Fayoum UniversityCollaborator
- Government of JapanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.